SB1502 updates Oklahoma’s Alzheimer’s Dementia and Other Forms of Dementia Special Care Disclosure Act. The bill requires nursing facilities, assisted living facilities, residential care facilities, adult day care centers, continuum of care facilities, and special care facilities that market themselves as providing memory care or dementia-specific services to disclose detailed information about those services. The required disclosure covers the facility’s philosophy of care, admission and discharge criteria, care planning, staffing ratios, staff training, physical environment, activities, family involvement, fees, and any relevant accreditations or certifications.
The bill also directs the State Department of Health to use a standardized disclosure form, maintain a public searchable database of filed forms, and review disclosures for completeness, accuracy, and currency during inspections. Referral agencies must provide access to the disclosure form for families considering placement, and facilities must post the form on their websites and display a complaint notice in the care area. The bill further clarifies that a facility without a special care unit or program is not barred from admitting a person with dementia, and it updates terminology throughout the statute.
A major structural change in SB1502 is the elimination of the Alzheimer-Dementia Disclosure Act Advisory Council as a continuing body under the statute, while still preserving a role for advisory input in rulemaking and form development. The bill amends the existing law to remove the prior council framework and replaces it with updated statutory language that keeps the disclosure and oversight system in place under the Department of Health.
The bill’s impact is primarily on long-term care regulation and consumer transparency. It expands and formalizes disclosure obligations for facilities that advertise memory care or dementia care, increases public access to facility information, and gives the Department of Health clearer oversight tools through standardized forms, inspections, and a public database. It also affects facilities, referral agencies, residents, families, and the Long-Term Care Ombudsman by making information about specialized dementia care more readily available.
The overall sentiment around the bill appears strongly favorable and noncontroversial. It advanced unanimously in the Senate Health & Human Services Committee, passed Senate third reading with no opposition, and also received unanimous “do pass” votes in the House Public Health Committee and the House Health and Human Services Oversight Committee. No committee transcript is available, but the voting history suggests broad bipartisan support for the transparency and consumer-protection goals of the measure.
The main point of contention, based on the text, is not opposition to disclosure itself but the administrative change of eliminating the advisory council. The bill preserves advisory input through the Department of Health and the commissioner, which suggests the legislature may have wanted to streamline oversight while keeping stakeholder expertise available. Any concerns would likely center on whether removing the standing council reduces consumer or industry representation in the rulemaking process, though the recorded votes do not show active disagreement.
SB1502 amends 63 O.S. 2021, Sections 1-879.2b and 1-879.2c, within the Alzheimer’s Dementia and Other Forms of Dementia Special Care Disclosure Act. It removes the statutory Alzheimer-Dementia Disclosure Act Advisory Council as a permanent body, updates definitions and cross-references, and expands the Department of Health’s role in collecting, reviewing, publishing, and inspecting disclosure information from memory-care providers. The bill affects licensed long-term care facilities, referral agencies, the Department of Health, the Long-Term Care Ombudsman, residents, and family representatives by increasing disclosure and public reporting requirements for dementia-related care services.
The bill appears to have received broad, unanimous support throughout the legislative process. Committee and floor votes in both chambers were all favorable and showed no recorded opposition, indicating a consensus that the measure improves transparency and oversight for dementia and memory-care services. The absence of recorded dissent suggests the bill was viewed as a technical and consumer-protection update rather than a controversial policy shift.
There is little evidence of active controversy in the available record. The only potentially sensitive issue is the elimination of the Alzheimer-Dementia Disclosure Act Advisory Council, which may reduce a formal stakeholder body that included both experts and consumer representatives. However, the bill preserves advisory input through the Department of Health and the commissioner, so any concern would likely be limited to governance structure and representation rather than the underlying disclosure requirements.